Acelrx Pharmaceuticals reported $5.26M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acelrx Pharmaceuticals ACRX:US USD 5.26M 1.56M
Baxter International BAX:US USD 782M 35M
Becton, Dickinson and BDX:US USD 1.18B 33M
Cara Therapeutics CARA:US USD 6.88M 658K
Heron Therapeutics HRTX:US USD 28.18M 3.94M
Intra Cellular Therapies ITCI:US USD 88.38M 11.94M
Johnson & Johnson JNJ:US USD 6.51B 423M
Pain Therapeutics PTIE:US USD 2.82M 150K
Pfizer PFE:US USD 4.87B 1.33B
Smiths SMIN:LN GBP 284M 17M
Teva Pharmaceutical TEVA:IT USD 777M 72M
Xeris Pharmaceuticals Inc XERS:US USD 34.49M 1.51M